Titre : | Failure of rechallenge clozapine after agranulocytosis: A case report (2019) |
Auteurs : | ROMEO Bruno, Aut. ; PETILLION A, Aut. ; MARTELLI C, Aut. ; BENYAMINA Amine, Aut. |
Type de document : | Article |
Dans : | ENCEPHALE (5 vol 45, 2019) |
Article en page(s) : | 449-450 |
Mots-clés : |
SANTEPSY CAS CLINIQUE ; CLOZAPINE ; EFFET SECONDAIRE ; SCHIZOPHRENIE RESISTANTE |
Résumé : | Clozapine is the standard treatment for resistant schizophrenia [1]. However, clozapine can cause side effects including heamatological side effects [2]. Given the clear benefit of clozapine use in patients with resistant schizophrenia, the reintroduction of this treatment after a side effect needs to be studied |
En ligne : | https://www.em-premium.com/article/1326597 |